Registry of Endoscopic Retrograde Cholangiopancreatographies Performed in Humans
Launched by ISTITUTO CLINICO HUMANITAS · Dec 9, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a procedure called endoscopic retrograde cholangiopancreatography (ERCP), which is often used to treat problems in the bile ducts and pancreas. ERCP combines a flexible tube with a camera (endoscope) and X-ray technology, allowing doctors to see and treat issues without needing major surgery. The trial aims to gather information about the ERCP procedures performed at one medical center, looking at factors like patient age, reasons for the procedure, any complications that may arise, and the tools used during the treatment.
To participate in this trial, you need to be at least 18 years old and scheduled for an ERCP at the ICH Gastroenterology and Digestive Endoscopy Unit. Unfortunately, individuals under 18 or those unable to give consent won’t be included. If you join, you can expect thorough monitoring during and after the procedure, as the researchers are interested in understanding both the benefits and potential risks, such as pancreatitis or other complications. Your participation will help improve future ERCP treatments and patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients will be recruited at the ICH Gastroenterology and Digestive Endoscopy Unit. The patients in question will be subjects of both sexes, over the age of 18 and who need to undergo ERCP.
- Exclusion Criteria:
- • Patients under 18 or unable to express informed consent.
About Istituto Clinico Humanitas
Istituto Clinico Humanitas is a leading clinical research organization based in Italy, dedicated to advancing medical science through innovative clinical trials and research initiatives. With a strong emphasis on patient-centered care and cutting-edge methodologies, the institute collaborates with various stakeholders in the healthcare sector to develop and evaluate new therapies and treatment protocols. Its multidisciplinary team of experts is committed to ensuring the highest standards of ethical practice and scientific rigor, contributing to significant advancements in medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rozzano, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials